(Press-News.org) BGI Europe A/S, a wholly owned subsidiary of BGI Genomics, announced its NIFTY® non-invasive prenatal testing kit and software (CE-IVDD List B) were granted an extension under its existing CE-IVDD certification to include the DNBSEQ-G99 model to meet the European Union regulations for medical devices.
In January 2024, BGI Genomics unveiled the NIFTY® ultra-fast non-invasive prenatal genetic testing product, utilizing the innovative DNBSEQ-G99 platform. Designed for both small and medium throughput, this platform ensures top-notch testing performance and quality. It enables clinical laboratories to provide quicker and more accurate prenatal genetic testing results. This advancement is crucial for timely genetic counseling and further prenatal diagnosis, enhancing prenatal care options.
Key Features of the DNBSEQ-G99 Platform:
Speed: The DNBSEQ-G99 platform dramatically reduces sequencing time to just 3 hours, with the entire process from sample collection to report generation taking only 14 hours. This efficiency significantly reduces the anxious wait for expecting families.
Flexibility: It allows for the processing of varying sample sizes in a single run, accommodating a minimum of 12 samples. This flexibility helps in minimizing reagent waste and cutting costs.
Versatility: The platform supports various sequencing modes and is suitable for a wide range of tests, including pre-embryo transplantation chromosome testing and monogenic disease carrier screening.
Simplicity: Featuring a cassette flow cell and an innovative pre-injected reagent design, the DNBSEQ-G99 simplifies the sequencing process, making it user-friendly for operators.
BGI Genomics has been a pioneer in non-invasive prenatal genetic testing since 2010. NIFTY® has received medical device qualifications in various countries, including the United Kingdom, Australia, Saudi Arabia, Turkey, India, and Thailand. BGI Genomics continues to upgrade its prenatal and neonatal tests, contributing to better public health systems and outcomes.
Guided by the vision of "Omics for all," BGI Genomics is dedicated to enhancing genetic testing technologies, thereby advancing global precision medicine and improving lives.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. To learn more about the NIFTY® Test - the world's leading non-invasive prenatal test (NIPT), please see this webpage. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
END
NIFTY® DNBSEQ-G99 platform receives CE-IVDD certification and advances prenatal care standards
2024-02-22
ELSE PRESS RELEASES FROM THIS DATE:
Living in violent neighborhoods affects children's brain development
2024-02-22
Living in neighborhoods with high levels of violence can affect children’s development by changing the way that a part of the brain detects and responds to potential threats, potentially leading to poorer mental health and other negative outcomes, according to research published by the American Psychological Association.
However, nurturing parents can help protect kids against these detrimental effects, according to the study, published in the journal Developmental Psychology.
“Decades of research ...
World’s first real-time wearable human emotion recognition technology developed!
2024-02-22
A groundbreaking technology that can recognize human emotions in real time has been developed by Professor Jiyun Kim and his research team in the Department of Material Science and Engineering at UNIST. This innovative technology is poised to revolutionize various industries, including next-generation wearable systems that provide services based on emotions.
Understanding and accurately extracting emotional information has long been a challenge due to the abstract and ambiguous nature of human affects such as emotions, ...
MD Anderson acquires inducible switch technologies for cell therapy
2024-02-22
HOUSTON ― The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe® switch platform and the GoCAR® platform. The transaction also includes clinical-grade stocks of rimiducid, an agent used to trigger the switches.
As a result of this acquisition, MD Anderson may incorporate these platforms into its own cell therapy programs. The institution also intends to make the technology ...
UTSA doctoral student studies solutions to prevent contaminated water sources
2024-02-22
From Bangladesh to India to Texas, Tom Varner is leveraging his research to improve sources for drinking water around the world.
Varner, a UTSA doctoral student in environmental science and engineering, explored the mobility of arsenic from the sediments surrounding the Meghna River in Bangladesh as part of a National Science Foundation-funded project.
The river flows through central Bangladesh, where elevated concentrations of arsenic in the groundwater threaten the welfare of millions of people. Long-term exposure to arsenic, which is toxic when ingested, can lead ...
Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomes
2024-02-22
A large-scale clinical trial of treatment strategies for Crohn’s disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve outcomes, including by reducing the number of people requiring urgent abdominal surgery for treatment of their disease by ten-fold.
The PROFILE trial, led by researchers at the University of Cambridge, involved 386 patients with newly-diagnosed active Crohn’s disease. Recruiting from 40 hospitals across the UK, and supported by the National Institute for Health and Care Research (NIHR) Clinical Research Network, it sought to test whether a biomarker – a genetic signature ...
Uncovering anxiety: Scientists identify causative pathway and potential cures
2024-02-22
Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals. Understanding the neural circuits and molecular mechanisms that trigger anxiety can aid in the development of effective targeted pharmacological treatments. Delta opioid receptors (DOP), which localize in the regions of the brain associated with emotional regulation, play a key role in the development of anxiety. Several studies have demonstrated the therapeutic effects of DOP agonists (synthetic compounds which selectively bind to DOPs and mimic the effect of ...
Stronger storms free more nutrients from mud flats
2024-02-22
If storms become stronger in the future due to climate change, more nitrogen may be released from the bottom of coastal seas. This is shown by research of marine biogeochemist Dunia Rios-Yunes at NIOZ in Yerseke. Rios-Yunes will defend her PhD-thesis today at the University of Utrecht. “The dynamics of nutrients in deltas and estuaries have been a bit of a blind spot for marine science, so far”, she says.
Inflatable couch
For her experiments, Rios-Yunes spent many hours on an inflatable couch on ...
New study is first step in predicting carbon emissions in agriculture
2024-02-22
MINNEAPOLIS / ST. PAUL (02/19/2024)—For the first time, researchers at the University of Minnesota Twin Cities (UMN) and the University of Illinois Urbana-Champaign (UIUC) have demonstrated that it is possible to provide accurate, high-resolution predictions of carbon cycles in agroecosystems, which could help mitigate the impacts of climate change.
The study by scholars from the UMN-led National Artificial Intelligence Institute for Climate-Land Interactions, Mitigation, Adaptation, Tradeoffs and Economy (AI-CLIMATE) and UIUC-led Agroecosystem Sustainability ...
Air pollution hides increases in rainfall
2024-02-22
We know that greenhouse gas emissions like carbon dioxide should increase rainfall. The emissions heat the atmosphere, causing a one-two punch: warmer oceans make it easier for water to evaporate, and warmer air can hold more water vapor, meaning more moisture is available to fall as rain. But for much of the 20th century, that increase in precipitation didn’t clearly show up in the data.
A new study led by researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley ...
Damage to cell membranes causes cell aging
2024-02-22
Our cells are surrounded by a fragile membrane that’s only 5 nanometers thick, 1/20 of a soap bubble. Cells are easily damaged by physiological activities, including muscle contraction and tissue injury. To cope with such damage, cells are equipped with mechanisms that can repair membrane damage to a certain degree.
Mechanical damage to the cell membrane was previously believed to trigger two simple cellular outcomes: recovery or death. In this study, however, the researchers uncovered a third outcome – cellular senescence.
“When I started this project, I simply aimed to understand ...